Zobrazeno 101 - 110
of 345
pro vyhledávání: '"Andrew L. Feldman"'
Autor:
Jose C. Villasboas, Joshua C. Pritchett, Stephen M. Ansell, Andrew L. Feldman, Zhi-Zhang Yang, James R. Cerhan, Hyo Jin Kim
Publikováno v:
Blood. 136:42-43
BACKGROUND: Angioimmunoblastic T cell lymphoma (AITL) has a unique histological profile comprised of a relatively small number of malignant CD4+ T-cells of TFH phenotype inter-mixed with an extensive infiltrate of multi-lineage immune cells. In our s
Autor:
Stephen Hamilton-Dutoit, Francesco d'Amore, N. Nora Bennani, Torben Steiniche, Rebecca L. Boddicker, Martin Bjerregård Pedersen, Christopher A. Sattler, Michael Boe Møller, Peter Nørgaard, Andrew L. Feldman, Rhett P. Ketterling, Patrick P. Bedroske, Ivy Luoma, Knud Bendix
Publikováno v:
Pedersen, M B, Hamilton-Dutoit, S J, Bendix, K, Ketterling, R P, Bedroske, P P, Luoma, I M, Sattler, C A, Boddicker, R L, Bennani, N N, Nørgaard, P, Møller, M B, Steiniche, T, d'Amore, F & Feldman, A L 2017, ' DUSP22 and TP63 rearrangements predict outcome of ALK-negative anaplastic large cell lymphoma : a Danish cohort study ', Blood, vol. 130, no. 4, pp. 554-557 . https://doi.org/10.1182/blood-2016-12-755496
To the editor: Peripheral T-cell lymphomas (PTCLs) represent a group of rare hematological cancers of mature T-cell or natural killer cell origin accounting for 10% to 15% of all lymphomas.[1][1] Although many patients have poor outcomes, some achiev
Autor:
Jose F. Leis, Betsy LaPlant, Asher Chanan-Khan, Casey N. Aitken, Xiaosheng Wu, Sameer A. Parikh, Michael J. Conte, Daniel L. Van Dyke, Huihuang Yan, Xin Liu, Rong He, Esteban Braggio, Timothy G. Call, Henan Zhang, Ivana N. Micallef, Grzegorz S. Nowakowski, Thomas M. Habermann, Andrew L. Feldman, Neil E. Kay, Thomas E. Witzig, Stephen M. Ansell, Shulan Tian, Sutapa Sinha, Patricia T. Greipp, Wei Ding, Linda Wellik, Yi Lin, Deborah A. Bowen, Erik Asmus, Haidong Dong, Charla R. Secreto, Tait D. Shanafelt, David S. Viswanatha, Gregory A. Wiseman, Jennifer Le-Rademacher
Publikováno v:
Blood. 129:3419-3427
Chronic lymphocytic leukemia (CLL) patients progressed early on ibrutinib often develop Richter transformation (RT) with a short survival of about 4 months. Preclinical studies suggest that programmed death 1 (PD-1) pathway is critical to inhibit imm
Autor:
Andrew L. Feldman, Marshall E. Kadin, Rhett P. Ketterling, Stephen M. Ansell, Surendra Dasari, Rebecca L. Boddicker, Karen L. Rech, Xueju Wang, Jagmohan S. Sidhu, William R. Macon
Publikováno v:
Human Pathology. 64:19-27
Anaplastic large cell lymphomas (ALCLs) are CD30-positive T-cell non-Hodgkin lymphomas that bear chromosomal rearrangements of the TP53 homologue TP63 in a subset of cases that demonstrate aggressive clinical behavior. In the present study, we examin
Autor:
Stephen M. Broski, Anthony Pham, Gregory A. Wiseman, Thomas M. Habermann, Dragan Jevremovic, Thomas E. Witzig, Andrew L. Feldman, Matthew J. Maurer, Kay M. Ristow
Publikováno v:
Leukemia & Lymphoma. 58:2342-2348
Staging of peripheral T-cell non-Hodgkin lymphoma (PTCL) is determined by 18-F FDG PET scan and bone marrow biopsy. This study addressed the accuracy of PET at detecting bone marrow (BM) involvement at restaging in patients with known involvement pre
Autor:
Surendra Dasari, Marshall E. Kadin, Grzegorz S. Nowakowski, Rebecca L. Boddicker, Xueju Wang, Andrew L. Feldman, Konstantinos N. Lazaridis, Eric D. Wieben
Publikováno v:
Oncotarget
// Xueju Wang 1, 2 , Surendra Dasari 3 , Grzegorz S. Nowakowski 4 , Konstantinos N. Lazaridis 5, 6 , Eric D. Wieben 5, 7 , Marshall E. Kadin 8 , Andrew L. Feldman 1, * , Rebecca L. Boddicker 1, * 1 Department of Laboratory Medicine and Pathology, May
Autor:
Karin Tarte, Thomas E. Witzig, Imane Azzaoui, Thomas M. Habermann, Andrew L. Feldman, Céline Pangault, Noel Milpied, Stephen M. Ansell, Thierry Fest, Marie Parrens, Matthew J. Maurer, James R. Cerhan, Delphine Rossille, Mikael Roussel, Susan L. Slager, Thierry Lamy, Gaëlle Labouré, Brian K. Link
Publikováno v:
Leukemia
Leukemia, Nature Publishing Group: Open Access Hybrid Model Option B, 2017, 31 (4), pp.988-991. ⟨10.1038/leu.2016.385⟩
Leukemia, 2017, 31 (4), pp.988-991. ⟨10.1038/leu.2016.385⟩
Leukemia, Nature Publishing Group: Open Access Hybrid Model Option B, 2017, 31 (4), pp.988-991. ⟨10.1038/leu.2016.385⟩
Leukemia, 2017, 31 (4), pp.988-991. ⟨10.1038/leu.2016.385⟩
Diffuse large B-cell lymphoma (DLBCL) is an aggressive hematologic malignancy with more than two-thirds of the patients cured with first-line rituximab-based treatments. However, relapsing or refractory patients have a very poor survival despite salv
Publikováno v:
Small GTPases. 10:33-39
Peripheral T-cell lymphomas (PTCLs) are rare, heterogeneous tumors with poor response to standard therapy and few targeted treatments available. The identification of mutations in the T-cell receptor (TCR) signaling pathway that either directly or in
Publikováno v:
J Clin Oncol
Publikováno v:
Mod Pathol